Ann: Dosing Completed in ATL1103 Clinical Trial , page-4

re: Ann: Dosing Completed in ATL1103 Clinical... I think what wormy is saying is that, "The ATL1103 Phase I trial remains blinded and as such the outcomes of the trial will not be known until the monitoring phase and all laboratory testing is completed.

The study is un-blinded after all the clinical trial data is entered into the trial database and the database locked for analysis. This process remains on track to be completed in time for the trial results to be reported by the end of this year (2011).

Thanks for the update wormy ;)